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Obesity, diabetes, and metabolic syndrome result
from complex interactions between genetic and
environmental factors, including the gut microbiota.
To dissect these interactions, we utilized three
commonly used inbred strains of mice—obesity/
diabetes-prone C57Bl/6J mice, obesity/diabetes-
resistant 129S1/SvImJ from Jackson Laboratory,
and obesity-prone but diabetes-resistant 129S6/
SvEvTac from Taconic—plus three derivative lines
generated by breeding these strains in a new, com-
mon environment. Analysis of metabolic parameters
and gut microbiota in all strains and their environ-
mentally normalized derivatives revealed strong
interactions between microbiota, diet, breeding
site, and metabolic phenotype. Strain-dependent
and strain-independent correlations were found be-
tween specific microbiota and phenotypes, some of
which could be transferred to germ-free recipient an-
imals by fecal transplantation. Environmental reprog-
ramming of microbiota resulted in 129S6/SvEvTac
becoming obesity resistant. Thus, development of
obesity/metabolic syndrome is the result of interac-
tions between gut microbiota, host genetics, and
diet. In permissive genetic backgrounds, environ-
mental reprograming of microbiota can ameliorate
development of metabolic syndrome.
INTRODUCTION
We are in the midst of worldwide epidemics of obesity, type 2
diabetes (T2D), and metabolic syndrome. These disorders pre-
sent as a spectrum of overlapping phenotypes from metaboli-
cally healthy obese individuals to those with full-blown T2D516 Cell Metabolism 22, 516–530, September 1, 2015 ª2015 Elsevieand metabolic syndrome, arising from a complex set of interac-
tions between genetic risk factors and environmental influ-
ences. Genome-wide association studies both in humans (Ng
et al., 2014; Saxena et al., 2007; Speliotes et al., 2010; Xia
and Grant, 2013) and rodents (Almind et al., 2003; Davis et al.,
2012; Yazbek et al., 2011) have identified multiple loci that
contribute to obesity and its associated metabolic abnormal-
ities, each with a small effect. A number of environmental mod-
ifiers of disease expression have been defined, including caloric
intake, dietary composition, levels of activity, and non-exercise-
related energy expenditure (Franks et al., 2013; Kahn et al.,
2006; Tuomi et al., 2014).
Recent studies in both rodents and humans indicate that
the gut microbiota is also a contributor to metabolic disorders
(reviewed in Khan et al., 2014). In general, obese humans and ro-
dents have less diverse gut communities than their lean counter-
parts (Le Chatelier et al., 2013; Serino et al., 2012; Turnbaugh
et al., 2009). Likewise, metagenomic studies have documented
differences in the microbial gene repertoires represented in the
gut communities of individuals with obesity (Greenblum et al.,
2012), T2D (Karlsson et al., 2013; Larsen et al., 2010), or nonal-
coholic fatty liver disease (Zhu et al., 2013). Evidence for a causal
relationship between the gut microbiota and metabolic dysfunc-
tions has come from studies showing that cohousing (Henao-
Mejia et al., 2012; Upadhyay et al., 2012) or antibiotic treatment
(Cox et al., 2014; Keeney et al., 2014) can modify obesity and
metabolic phenotype in rodent models. Transplantation of fecal
microbiota from obese versus lean mice, obese versus lean hu-
mans, and human twin pairs stably discordant for obesity into
germ-freemouse recipients transmits donor adiposity andmeta-
bolic phenotypes (Le Roy et al., 2013;Million et al., 2013; Ridaura
et al., 2013). Some of the effects of gastric bypass surgery on
obesity and metabolic dysfunction have also been related to
changes in gut microbiota (Liou et al., 2013). While cross-
sectional studies and short-term experiments assessing effects
of microbiota transfer have provided important insights into the
role of gut microbiota in metabolic syndrome, additional ap-
proaches are needed to assess the long-term nature of normal
environmental changes and the complex interaction betweenr Inc.
host genetics, diet, and the microbiota in the regulation of
metabolism.
We and others have previously shown that C57BL/6J mice
(B6J) gain more weight, have more insulin resistance, and
show greater glucose intolerance than 129S1/SvImJ (129J)
mice obtained from the same production facility. These pheno-
typic differences are further exacerbated by high-fat diet (HFD)
(Almind and Kahn, 2004; Almind et al., 2007) or imposition of ge-
netic defects in insulin signaling (Kulkarni et al., 2003), illustrating
the strong impact of strain background on both genetic and envi-
ronmentally induced insulin resistance. In the present study, we
have characterized interactions between host genetics, diet, and
the gut microbiota by conducting longitudinal analyses of the
responses of three commonly used inbred strains of mice to
long-term environmental conditioning as well as to shorter-
term dietary challenges. Two of the strains were the B6J and
129J mice described above from the Jackson Laboratory (Jax).
The third was the 129S6/SvEvTac strain from Taconic Farms
(129T) (Almind et al., 2003; Mori et al., 2010), which is closely
related to the 129J strain but is bred in a different facility and
treated with a probiotic mixture, thereby creating a substantial
difference in their microbiota (Ivanov et al., 2009). In addition,
we have created three environmentally normalized groups by
inbreeding each of the strains for three to six generations in
our own animal facility under a common set of conditions.
We show that, in contrast to obesity- and diabetes-resistant
129J mice, genetically related 129T mice resemble B6J mice
in their susceptibility to develop diet-induced obesity and
enlarged livers on HFD, but retain normal insulin sensitivity
and develop only mild glucose intolerance. Interestingly, these
differences in weight gain and glucose tolerance between
129J and 129T mice were lost after rearing these mice in the
same environment for more than three generations. Using bac-
terial 16S rRNA sequencing and fecal microbiota transplants to
germ-free recipient mice, we demonstrate that both the original
differences in phenotypes and their changes following environ-
mental normalization and dietary challenge are closely related
to the gut microbiota, and that the composition of microbiota
is highly dependent on diet, environmental history, and host
genetics. We also demonstrate strong mouse strain-dependent
and strain-independent relationships between specific meta-
bolic phenotypes and specific bacterial taxa or communities,
indicating the strong, complex, and dynamic interactions be-
tween the microbiota, diet, environmental ancestry, and host
genetics.
RESULTS
Susceptibility to Weight Gain and Insulin Resistance Is
Influenced by Genetic Background and Environmental
Origin
B6J and 129J mice exhibit major differences in their tendencies
to gain weight and develop diabetes and metabolic syndrome
with age or consumption of a HFD. As previously reported (Al-
mind and Kahn, 2004; Almind et al., 2007), when 4-week-old,
vendor-bred B6J male mice were placed on a NIH-31M chow
diet (CD) and followed for 22 weeks, they gained significantly
more weight than 129J mice, also from Jax Labs (Figure 1A,
left panel). This difference inweight gain was further exaggeratedCell Mewhen themice were fed a HFDwith 60%of calories from fat (Fig-
ure 1A, right panel). When these diets were given to 129T mice,
the result was remarkably different with 129T mice being as
prone to weight gain as the B6J animals (Figure 1A and see
Figure S1A available online).
Among the three strains of mice, B6J animals had the highest
fasting glucose levels and the greatest level of hyperglycemia
following an intraperitoneal glucose tolerance test (GTT). This
was true in CD-fed mice and exacerbated further by HFD (Fig-
ure 1B). 129J mice had a trend to lower fasting glucose levels
and significantly lower excursions during GTT than B6J mice
on both CD and HFD (Figure 1B). Interestingly, despite having
similar body weights on CD, glucose tolerance was better in
129T than in 129J mice, whereas on HFD, both had similar im-
pairments of glucose tolerance, although the 129T mice gained
more weight than the 129J mice (Figures 1A, 1B, and S1A).
Importantly, both 129 strains remained insulin sensitive
compared to B6J mice with lower basal insulin levels and
HOMA-IR levels, even after 22 weeks of HFD (Figures 1C, 1D,
and S1B). On CD both 129 strains had higher serum levels of
PYY and GIP compared to B6J mice, and 129T mice had higher
levels of FGF21 (Figure S1C). When challenged with HFD, all
three strains also showed 6- to 10-fold increases in hepatic tri-
glyceride concentration (Figure 1E). However, there were major
differences in degree of hepatomegaly among strains, with a
150% increase in liver weight in B6J mice, a 130% increase in
129T mice, and only a 30% in 129J mice (Figure 1F). Changes
in tissue inflammatory markers in the three strains of mice, on
the other hand, closely followed the differences in insulin resis-
tance, with higher levels of TNF-a, IL-6, and F4/80 in B6J fat
and liver compared to both 129 strains, especially on HFD (Fig-
ure 1G). Thus, B6J mice gain more weight and exhibit all of the
features of metabolic syndrome when placed on HFD, whereas
129J are resistant to weight gain and protected from metabolic
syndrome (Table S1). 129T mice, on the other hand, have a
unique blend of features, being prone to obesity and hepatostea-
tosis on HFD but protected from insulin resistance, thus resem-
bling the more metabolically healthy subgroup of obese humans
(Samocha-Bonet et al., 2014).
‘‘Environmental Normalization’’ Changes Susceptibility
to Metabolic Syndrome
To determine to what extent genetic versus environmental differ-
ences at the commercial animal facilities contribute to these dif-
ferences in susceptibility to metabolic syndrome, each of these
vendor-bred mouse strains was imported into our animal facility,
housed in separate cages in this common environment, and then
inbred for three to six generations (Figure 2A). The resulting new
lines were designated B6J/Jos, 129J/Jos, and 129T/Jos. The
three Jos-born strains, as well as cohorts of mice imported
directly from Jackson and Taconic, were fed either a CD or
HFD for 22 weeks, starting at 4 weeks of age. Whereas B6J/
Jos and 129J/Jos mice behaved similarly to the vendor-bred
mice in terms of weight gain (i.e., B6J/Jos mice gained more
weight on both CD and HFD than 129J/Jos mice), after three
generations of inbreeding in a new environment, 129T/Jos
mice gained significantly less weight, especially during the first
8 weeks of the study, on both CD and HFD than their vendor-
bred counterparts (Figures 2B and 2C; Table S1).tabolism 22, 516–530, September 1, 2015 ª2015 Elsevier Inc. 517
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Figure 1. Differences in Weight Gain and Glucose Tolerance between Vendor-Bred Mouse Strains
(A) Weight gain curves of B6J, 129J, and 129T mice on CD and HFD (n = 19–20 per group).
(B) Intraperitoneal GTT of vendor-bred strains at 10 weeks on the indicated diets (n = 6). Repeated-measure two-way ANOVA (time and strain) with Bonferroni
post hoc test for (A) and (B).
(C andD) (C) Insulin levels measured in nonfasted animals and (D) calculated HOMA-IR after 22weeks of CD andHFD (n = 6 per treatment group; two-way ANOVA
[strain and diet] with Sidak’s post hoc test).
(E and F) (E) Liver triglyceride (TG) content (n = 4) and (F) liver weight (n = 6) in mice after 22 weeks of consumption of CD and HFD. Two-way ANOVA (diet
[p < 0.0001] and strain [p = 0.0004]; interaction p = 0.0054) with Bonferroni post hoc test.
(G) qPCR for inflammatory markers expressed in perigonadal fat (n = 8) or liver (n = 4) harvested from mice fed CD or HFD for 22 weeks. Data are normalized to
TBP (one-way ANOVA with Tukey’s post hoc test). ***p < 0.001, **p < 0.01, *p < 0.05. All values presented as mean ± SEM. See also Figure S1.Other components of metabolic syndrome were modified to
different extents by environmental normalization. For example,
the difference in glucose tolerance observed between 129J
and 129T mice imported from the vendor disappeared
completely after environmental normalization such that 129J/
Jos and 129T/Jos mice had virtually identical glucose tolerance
on CD and similar levels of glucose intolerance on HFD, both of
which were significantly better than the B6J/Jos mice, which
were quite glucose intolerant on both diets (Figure 2D). Likewise,
although hepatic triglyceride content increased significantly in all
three Joslin-bred strains when challenged with HFD, the differ-
ences in liver weight on HFD between the two 129J and 129T
mice disappeared in the two environmentally normalized strains
(Figures 2E, S2A, and S2B). By contrast, environmental normal-
ization had little effect on inflammation. Both B6J and B6J/Jos518 Cell Metabolism 22, 516–530, September 1, 2015 ª2015 Elseviemice fed a HFD showed marked increases in inflammatory
markers in visceral adipose tissue and liver compared to all
129 strains, which showed little inflammation in these tissues
(Figures 2F and S2C).
Both B6J and B6J/Jos mice had higher levels of insulin and
HOMA-IR, especially on HFD, than did either strain of the
vendor-bred or Joslin-bred 129 mice (Figures 2G and 2H), indi-
cating the higher level of insulin resistance in the B6J and B6J/
Jos mice before and after environmental normalization. The dif-
ferences in enteroendocrine hormones (GIP, PYY, and FGF21)
also persisted in the Joslin-bred strains (compare Figure S1C
and Figure S2D).
Thus, environmental normalization eliminated many of the dif-
ferences observed in the two vendor-bred strains of 129 mice,
such that both 129J/Jos and 129T/Jos mice showed similarr Inc.
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Figure 2. Phenotypic Changes Associated with Breeding at Joslin
(A) Schematic overview of the experimental design, indicating study groups and time points of fecal sampling.
(B and C) (B) Body weight gain of Joslin-bred mice (B6J/Jos, 129J/Jos, and 129T/Jos) on either CD or (C) HFD (n = 19–20 per group). Symbols show statistically
significant differences between the indicated groups as judged by a repeated-measures two-way ANOVA (time and strain) with Bonferroni post hoc test.
(D) Intraperitoneal GTT of Joslin-bred mice tested after 10 weeks on either CD or HFD (n = 6 per group; symbols show significant differences between the
indicated groups as judged by a repeated-measures two-way ANOVA [time and strain] with Bonferroni post hoc test).
(E) Liver weight of Joslin-bred strains at 22 weeks (two-way ANOVA [diet and strain] with Tukey’s post hoc test; n = 6).
(F) Heatmap of gene expression in perigonadal fat (PGF) (n = 8) and liver (n = 4) after 22 weeks on either CD or HFD.
(G and H) (G) Insulin levels measured after 22 weeks of CD and HFD in nonfasted animals and (H) calculated HOMA-IR (n = 6 per treatment group, two-way
ANOVA [diet and strain] with Tukey’s post hoc test]. ***p < 0.001, **p < 0.01, *p < 0.05. All values presented as mean ± SEM. See also Figure S2.levels of glucose tolerance and were resistant to weight gain and
hepatosteatosis on HFD (Table S1). By contrast, environmental
normalization had no effect to ameliorate diet-induced obesity,
insulin resistance, hepatosteatosis, or tissue inflammation in
B6J animals, which remained prone to all aspects of the meta-
bolic syndrome regardless of site of breeding.
Mechanisms Underlying Differences in Weight Gain and
Inflammation
To better define the mechanisms underlying differences in
weight gain, food intake, and energy expenditure, the strains
were assessed in CLAMS metabolic cages 8 weeks into the
study. Despite exhibiting less weight gain, both 129J and 129T
mice tended to eat more on CD than B6J mice (Figure 3A). The
differences in weight gain on HFD could not be explained by
differences in caloric intake or by differences in spontaneous ac-
tivity. B6Jmice, which gained themost weight, were significantly
more active than 129J, with 129T mice being intermediate with
no difference between the original strains and their Joslin-bred
counterparts (Figure 3B). Metabolic rates (i.e., oxygen consump-
tion [VO2] and carbon dioxide [VCO2] production) were signifi-
cantly higher in 129T than B6J mice especially on HFD, andCell Meintermediate in 129J mice (Figures 3C and 3D). The tendency
to higher metabolic rate in 129J compared to B6J mice could
contribute to their obesity resistance. Respiratory exchange ra-
tios (RERs) were similar in all three original strains on CD, tended
to be higher in 129J/Josmice, andwere significantly increased in
129T/Josmice compared to the original strains. All mice showed
similar reductions upon HFD feeding (Figure 3E). Thus, 129J
mice tended to eat more, were less active than B6J mice, and
were resistant to weight gain primarily due to a higher basal
metabolic rate. 129T mice also had a higher metabolic rate
than B6J mice, but were slightly less active and ate slightly
more, allowing them to gain similar amounts of weight as B6J
mice on HFD. Three generations of breeding in the new environ-
ment reversed the tendency to gain weight in 129T/Jos mice by
inducing small decreases in food intake and small increases in
metabolic rate.
Influence of Genetic Background, Birthplace, and Diet
on Gut Microbiota
To characterize the fecal microbiota of mice with different
genetic backgrounds, birthplaces, ancestral origins (i.e., de-
scended from Tac mice or Jax mice), and diets, we sequencedtabolism 22, 516–530, September 1, 2015 ª2015 Elsevier Inc. 519
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Figure 3. Food Consumption, Activity and
Metabolic Rates in Vendor-Bred and
Joslin-Bred Strains
(A) Daily food intake per gram lean body mass, (B)
total activity (beam breaks/30 min), (C) oxygen
consumption (VO2), (D) carbon dioxide production
(VCO2), and (E) respiratory exchange ratio after
8 weeks on the indicated diets as measured in
metabolic cages (n = 5–8 per group; two-way
ANOVA [diet and strain] with Bonferroni post hoc
test for A, B, and E; one-way ANOVA with Tukey’s
post hoc test for C and D; ***p < 0.001, **p < 0.01,
*p < 0.05). All values presented as mean ± SEM.variable region 4 (V4) of bacterial 16S rRNA genes present in the
287 fecal samples collected over the course of the experiments
described in Figure 2A and analyzed as described in Supple-
mental Experimental Procedures (Table S2).
Principal coordinates analysis (PCoA) plot of unweighted Uni-
Frac distances between all 287 samples showed that the first
principal coordinate (PC1), which explains the greatest variance,
segregated samples by diet, while the second coordinate (PC2)
segregated them by ‘‘birthplace’’ (Jax, Tac, and Jos) and strain
(B6, 129J, and 129T) (Figure 4A). These three major driving
forces are even more apparent when samples are separated
by experimental week (Figures 4B and S3A). At time 0, when520 Cell Metabolism 22, 516–530, September 1, 2015 ª2015 Elsevier Inc.all animals were 4 weeks of age and had
been only on CD sinceweaning, themajor
separation was by site of breeding
(vendor versus Joslin) with lesser but
clear differences among the strains.
Within 1 week of HFD feeding, both
vendor- and Joslin-bred mice showed a
major rightward shift along PC1, which
persisted during the entire 22 week die-
tary challenge (Figure 4B). In addition,
over time, there were shifts along PC2
such that the differences between
vendor-bred and Joslin-bred mice of all
strains tended to converge, although
some differences remained (Figure 4B).
Similar results were obtained when the
PCoA analysis was performed for data
collected each week: the plots separate
Jax and Jos bred mice from the Tac
bred 129T even more clearly, illustrating
the unique phylogenetic composition of
the microbiota in the Taconic vendor-
derived animals (Figure S3A).
Permutational multivariate analysis
of variance (PERMANOVA; see Supple-
mental Glossary and Supplemental
Experimental Procedures) demonstrated
that at week 0, when all three vendor-
bred strains and the corresponding
three Joslin-bred mice were consuming
CD, birthplace accounted for 33.8% of
the variance in microbial diversity (asmeasured by UniFrac distances), while ‘‘strain’’ (129 versus B6)
and ‘‘ancestral origin’’ (Tac versus Jax) accounted for 10.2%
and 4.3%, respectively. These influences were illustrated by
the fact that Joslin-bred 129T/Jos and 129J/Jos mice harbored
microbial communities that were more phylogenetically similar
to each other than either was to B6J/Jos, whereas in vendor-
bred animals, the B6J and 129J microbial communities were
more similar to each other than eitherwas to the 129T (Figure 4C).
With increasing time at Joslin, CD-fed vendor-bred mice devel-
oped microbiota that manifested increasing phylogenetic simi-
larity to their corresponding Joslin-bred strains (Figures 4B–4F,
S3B, and S3C). This occurred despite the fact that none of the
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Figure 4. Phylogenetic Similarity and Phylogenetic Diversity of Fecal Microbiota
(A) PCoA of unweighted UniFrac distances for all 287 fecal samples, with fitted vectors indicating the effects of diet and birthplace calculated using weighted
mean positions along principal coordinates 1 and 2 (PC1 and PC2).
(B) PCoA of unweighted UniFrac distances for all 287 fecal samples, separated by week.
(C) Percent phylogenetic similarity [calculated as 1003(1 unweighted UniFrac distance)] within each experimental group ofmice and between the three vendor-
bred strains and the three Joslin-bred strains at week 0 of the experiment. Comparisons of selected mean distances within and between experimental treatment
groups were performed using permutation tests with 10,000 randomizations, followed by Holm’s corrections for multiple tests. Shown are means and boot-
strapped 95% confidence intervals.
(D) Pie charts showing relative abundances of bacterial phyla in the fecal microbiota of mice at the indicated time points and diets.
(E) Phylogenetic diversity of the fecal microbiota of all strains at week 0 on CD and at week 22 on both CD and HFD. Differences between means were tested for
significance using twoANOVAs, one for week 0 and one for week 22, followedby planned contrasts ofmeanswith p values adjusted using the single-stepmethod.
(F) Relative abundances of Joslin-specific OTUs that colonize 129J, 129T, and B6J mice over time (± SEM). Differences between the mean relative abundances
were testedwithin eachmouse strain for CD-fedmice at weeks 0 and 22, and for CD-fed versus HFD-fedmice at week 22, using t tests and Holm’s corrections for
p values. ***p < 0.001, **p < 0.01, *p < 0.05. See also Figure S3.
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different groups of mice were ever cohoused. Despite this
convergence of the microbial communities, birthplaces, ances-
tral origins, and strain/genetics still significantly contributed to
the observed variance among fecal microbiota at week 22, but
to a much lower extent (PERMANOVA, 9.5%, 3.4%, and 6.2%,
respectively). As in the PCoA analysis of all samples, at week
22, diet (CD versus HFD) had the greatest influence on commu-
nity structure, explaining 16.8% of the variance (Figures 4A, 4B,
and S3A). Some of these patterns could also be seen in the rela-
tive abundances of bacterial phyla in the mice’s fecal microbiota
(Figure 4D). For example, the fecal microbiota of CD-fed 129T
mice at week 0 differed from all others in that the Firmicutes
weremore dominant, and the Bacteroidetes and Deferribacteres
had roughly equivalent relative abundances, which were far
below the Bacteroidetes representation in all other groups. Dur-
ing the 22 weeks on CD, most mouse strains showed only
modest changes in microbiota structure at the phylum level,
except for 129Tmice, which demonstrated a significant increase
in the relative abundance of Bacteroidetes (4.0% ± 1.1% to
19.6% ± 4.1%; p = 0.0007; Wilcoxon rank sums test) accompa-
nied by decreases in Firmicutes (89.9% ± 2.0% to 77.5% ±
3.8%; p = 0.003; Wilcoxon rank sums test) and Deferribacteria
(2.8% ± 1.3% to 0.2% ± 0.03%; p = 0.003; Wilcoxon rank
sums test). On the other hand, all host strains showed major
changes in microbiota configuration after 22 weeks on HFD,
with an increase in Firmicutes (p = 6.6 3 1011, Kruskal-Wallis
test) and a decrease in Bacteroidetes compared to CD (p =
1.0 3 1012, Kruskal-Wallis test; Figure 4D).
When sampled at week 0, phylogenetic diversity (PD) did
not differ among the three vendor-bred strains or among the
three Joslin-bred strains. However, the fecal microbiota of all
vendor-bred mice had significantly lower PD than their Joslin-
bred counterparts (Figure 4E; ANOVA, p < 106). After 22 weeks
on CD at Joslin, the PD of the three vendor-bred strains
increased, but remained lower than their Joslin-bred counter-
parts, especially in the B6J and 129J mice. HFD feeding re-
sulted in significantly reduced PD in all mice. Interestingly,
even after 22 weeks on HFD, the PD in the vendor-bred mice
was significantly lower than their Joslin-bred counterparts (Fig-
ure 4E). The relative abundances of Joslin-specific OTUs that
colonized 129J, 129T, and B6J mice increased over time in all
three strains of mice; this colonization by Joslin-derived taxa
was greatest in each mouse strain on CD (Figure 4F). Thus,
early environmental exposures impacted the response to
HFD; this diet prevented vendor-bred strains from developing
fecal microbiota as phylogenetically diverse as their Joslin-
bred counterparts.
OTUs Associated with Birthplace, Ancestral Origin,
and/or Strain of Mice
To identify specific bacterial OTUs that differed in occurrence
among B6J, 129J and 129T mice and their Joslin-bred counter-
parts, we performed multi-level pattern analysis (MPA) (De Ca-
ceres et al., 2010) (see Supplemental Experimental Procedures
and Glossary). Of the 2,816 OTUs detected at week 0, 240 had
significant associations with one or more of the groups (Fig-
ure 5A; Table S3 and Table S4). Hierarchical clustering of the
mouse groups (strain 3 origin) based on the phi-coefficients
of the most common, significantly associated OTUs showed522 Cell Metabolism 22, 516–530, September 1, 2015 ª2015 Elsevievendor-born and Joslin-bred mice clustering apart from each
other (Figure 5A). Interestingly, within vendor-born mice, B6J
and 129J mice (both Jackson bred) clustered together, while af-
ter environmental normalization 129T/Jos and 129J/Jos mice
clustered together. This suggests that host genotype may play
a more important role in determining the occurrence of OTUs
in mice bred at Joslin.
This analysis also demonstrated that the low phylogenetic di-
versity in the vendor-bred mice was due, in large part, to the fact
that, in the vendor-bred strains, only six OTUs assigned to Bac-
teroidetes were present at a mean relative abundance >0.1%.
Indeed, 129Tmice had only one Bacteroidetes OTU (Parabacter-
oides goldsteinii) above this threshold level of abundance. By
contrast, members of the phylum Bacteroidetes represented a
substantial amount of the bacterial diversity in the Joslin-bred
strains (Figure 5B; Table S4). Given the phenotypic differences
between 129T and 129T/Jos mice, OTUs that differed between
these two lines were of particular interest. MPA identified 21
OTUs strongly and uniquely associated with vendor-bred 129T
mice at time 0. Interestingly, all of these were members of the
Firmicutes, and included OTUs for Blautia producta and three
Clostridial species. In addition, 53 OTUs were identified in the
Joslin-bred 129T/Jos mice that were not present in the vendor-
bred 129T animals (Figure 5A; Table S4).
Using nonparametric Kruskal-Wallis tests with p values
adjusted for false discovery rate, under the Benjamini-Hochberg
method (Benjamini-Hochberg-adjusted p values), we identified
226 OTUs that differed significantly in their relative abundances
in the fecal microbiota of CD- versusHFD-fedmice in at least one
strain after 22 weeks. One hundred forty-five of these OTUs,
including 34 members of the Bacteroidetes, exhibited signifi-
cantly higher relative abundances in mice fed CD. By contrast,
74 OTUs in the Firmicutes exhibited consistent increases in rela-
tive abundance on HFD (Figure S5; Table S5). HFD led to the
apparent loss of nine OTUs from all Joslin-bred strains, including
six Joslin-associated Bacteroidetes.
Correlations between Bacterial OTU Abundances and
Mouse Phenotypes
Spearman’s rank correlations were used to identify bacterial
OTUs whose relative abundances at week 22 were strongly
correlated with one or more of the 36 phenotypes we quantified
(see Experimental Procedures). Considering only the 383 OTUs
with a relative abundance >0.1% in one of the 12 mouse-by-
diet groups, 780 OTU-phenotype pairs, involving 135 OTUs,
had Spearman’s correlations stronger than 0.5 or 0.5 (Fig-
ure 6A; Table S6). Of these, 771 involved phenotypes and
OTUs that were significantly influenced by at least one shared
experimental factor, and for 726 of these, the common factor
was response to HFD (Figure 6A; Table S6B). Thus, HFD
increased the relative abundance of Firmicutes in all six strains
of mice with increases in a number of specific Firmicutes.
Several of these OTUs, assigned to Clostridiales, Roseburia
intestinalis, and Ruminococcaceae, were positively correlated
with specific metabolic phenotypes (Figures 6A and 6B). These
correlations could be the result of a direct causal relationship be-
tween the relative abundances of OTUs and mouse phenotypes
or could arise because both the OTUs and phenotypes are linked
to another common variable such as HFD. Correlations withr Inc.
AB
Figure 5. Representation of Bacterial Taxa in the Fecal Microbiota
(A) Heatmap showing the phi-coefficients of OTUs that have at least one significant phi-coefficient more extreme than0.8 or 0.8 or mean relative abundance of
at least 1% in at least one group of mice at week 0 of the experimental period.
(B) Abundance of OTUs assigned to the phylum Bacteroidetes in vendor-bred and Joslin-bred mouse strains. All Bacteroidetes OTUs with mean relative
abundances of 0.1% or greater in at least onemouse group are included in the heatmap. Abundance values were log-transformed according to the formula log10
(abundance/10,000 reads +1). Also see Figure S4.Lactococcus lactiswere also observed, but were not considered
biologically significant, since the HFD, although twice irradiated,
contained DNA of L. lactis, which is used in production of casein,
a component of the diet. This L. lactis was nonviable by culture,
as also previously described (Carmody et al., 2015), but was
easily detected by 16S rRNA sequencing.
To identify OTU-phenotype correlations that persisted after
controlling for the influences of mouse genetic backgroundCell Meand diet, we calculated Spearman’s correlations using only
129 mice (129T, 129T/Jos, 129J, and 129J/Jos) on HFD. Only
four correlations survived multiple test corrections (Benjamini-
Hochberg-adjusted p value < 0.5), all in HFD-fed 129 mice (Fig-
ure 6C; Table S7). These correlations included a strong positive
correlation between body weight and OTU 95638 (Mucispirillum
schaedleri) and strong negative correlations between OTU
191491 (Clostridium scindens) and body weight and FGF21,tabolism 22, 516–530, September 1, 2015 ª2015 Elsevier Inc. 523
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Figure 6. Correlations between OTUs’ Relative Abundances and Phenotypes, Including All Mouse Groups
(A) A heatmap shows Spearman’s rank correlations between phenotypes and the relative abundances of selected OTUs. OTUs with at least four correlations
more extreme than 0.5 or 0.5 or one correlation more extreme than 0.75 or 0.75 are shown. All phenotypes with at least one correlation more extreme than
0.5 or 0.5 are presented. Hierarchical clustering is presented for both OTUs and phenotypes, based on the Euclidean distances between their presented
Spearman’s rank correlations.
(B) Linear correlations between the mean relative abundances (per 10,000 reads) of select OTUs and mouse phenotypes for each of experimental treatment
groups.
(C) Heatmap of Spearman’s correlations between phenotypes and the relative abundances of OTUs using all HFD-fed 129mice (129T, 129T/Jos, 129J, and 129J/
Jos). p values were corrected for false detection rate using the Benjamini-Hochberg method and significant correlations after correction are highlighted with a
yellow box. See also Figure S5.
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and another strong negative correlation between OTU 166592
(Clostridiales) and free fatty acid.
We also calculated Spearman’s correlations focusing on the
HFD-fed mice for each of the three genetic backgrounds sepa-
rately, combining B6J and B6J/Jos, 129J and 129J/Jos, and
129T and 129T/Jos, thus allowing us to identify the specific
associations for each genetic background. For 129T and 129T/
Jos mice, 133 correlations stronger than 0.5 or 0.5 were iden-
tified (Figures S5A and S5B; Table S8). Seven OTUswere related
to bodyweight (two positive, including OTU 95638 [Mucispirillum
schaedleri] and OTU 470527 [Lactobacillus reuteri], and five
negative, including four OTUs in the order Clostridiales and
OTU 1698560 [Bacteroidales]). Four of the five OTUs that nega-
tively correlated with body weight also negatively correlated with
weight of the subcutaneous (inguinal) fat pad, as did OTU
293221, which was identified as the saccharolytic, butyrate-pro-
ducingmicrobeRoseburia intestinalis. Five OTUs correlated with
visceral (perigonadal) fat pad weight, but none of these were the
same as those related to body or subcutaneous fat pad weight.
On the other hand, insulin levels correlated with the abundance
of six microbiota (five positively and one negatively), and of
these, two also positively correlated with perigonadal fat pad
weight, including OTU 266246 (Eubacterium plexicaudatum)
and Clostridiales OTU 269418. Although 129T and 129T/Jos
mice have much less adipose inflammation than B6J mice
even at similar body weights, OTU 292302 (Lactobacillus
murinus) and Lactobacillus OTU 422931 showed correlations
to markers of inflammation (expression of IL-6 and MCP-1) in
perigonadal fat (Figure S5A).
Despite the high level of genetic similarity between 129T and
129J mice and their respective Joslin counterparts, of the 182
OTUs that could be related to specific phenotypes in 129J and
129J/Jos mice, only two showed correlations in the same direc-
tion, including the Clostridiales OTU 321691, which negatively
correlated with body weight and FGF21 levels in both strains
(Figures S5A–S5D; Table S8). On the other hand, despite repre-
senting different genetic backgrounds and different vendors of
origin, the two strain pairs that had some propensity to develop
components of metabolic syndrome—the B6J and B6J/Jos pair
and 129T and 129T/Jos pair—shared five correlations. Thus, in
both groups, body weight was negatively correlated with
the relative abundances of OTU 402711 (Clostridium lactatifer-
mentans) and Clostridium OTU 165762 (Figures S5A, S5B,
S5E, and S5F). Likewise, in these pairs, FGF21 levels positively
correlated with L. reuteri and negatively correlated with
C. lactatifermentans, while serum free fatty acid levels were
negatively correlated with OTU 323257 (L. gasseri). Consistent
with the group-wise analysis across all mouse strains on both
CD and HFD (Figure 6B), L. gasseri was strongly positively asso-
ciated with insulin levels in animals from both strain pairs origi-
nating from Jax (129J and 129J/Jos; and B6J and B6J/Jos),
even when the analysis was restricted to mice on HFD only (Fig-
ure S5A; see Table S8 for a complete list of correlations).
In B6J mice, which is the most commonly used strain for the
study of metabolic syndrome, inflammation in adipose tissue
and liver has been linked to the pathogenesis of metabolic syn-
drome (Mori et al., 2010), and the gut microbiota has been linked
to the inflammatory response (Chassaing et al., 2014). Impor-
tantly, in this strain pair, several OTUs showed robust correla-Cell Metions with multiple markers of inflammation, including strong
positive correlations between levels of CD68, F4/80, CD11c,
IL-6, and TNF-a in adipose tissue and the abundance of OTU
278234 (Akkermansia muciniphila), and weak correlations of
these markers with OTU 302844 (Clostridium disporicum), OTU
258906 (Clostridium scindens), and another Clostridiales (OTU
321691) (Figures S5E and S5F). Interestingly, none of these
correlations were observed in the 129J-129J/Jos strain pair,
which shows almost no inflammatory changes in adipose tissue
when challenged with HFD (Figures S5C and S5D). In the 129T-
129T/Jos pair, HFD induces a low level of inflammation in
adipose tissue (Figure 2F), and in this pair, only two markers of
inflammation in fat (IL-6 and MCP-1) showed any correlation
with OTUs, (see LactobacillusmurinusOTU292302 and Lactoba-
cillus OTU 422931 in Figures S5A and S5B).
Transplant Studies to Identify Microbiota-Transmissible
HFD-Associated Phenotypes
To more directly investigate the causal relationships of these
various microbiota in the development of metabolic syndrome,
we colonized 6-week-old germ-free C57Bl/6 mice with the cecal
microbiota from age-matched, vendor-born B6J, 129J, and
129T mice. Germ-free animals were started on HFD 1 week prior
to colonization and maintained on this diet for an additional
8 weeks after receiving fecal transplants from the vendor-born
donors (n = 9 recipients/donor microbiota). Recipients of all three
microbiota gained significantly more weight throughout the
study compared to germ-free controls that were not colonized.
While weight gain did not differ between mice colonized with
the different microbiota over the course of the 8-week experi-
ment (Figure 7A), the mean value for nonfasting serum glucose
6 weeks after transplant was significantly greater for mice
harboring a B6J microbiota than those colonized with a 129J
microbiota, andmarginally greater than those with a 129Tmicro-
biota (Figure 7B; ANOVA, p = 0.021). Differences in random-fed
blood glucose did not differ at 8 weeks. However, assessment
of glucose homeostasis at 8 weeks, assessed by oral glucose
tolerance testing, revealed that animals colonized with a
vendor-born 129T donor microbiota had significantly greater
AUC values than recipients of a vendor-born 129J donor micro-
biota, with an intermediate phenotype exhibited by B6J recipi-
ents (Figure 7C; ANOVA, p = 0.001). Mice colonizedwith different
microbiota also had marginally significant differences in their
liver weights relative to their total body weights (ANOVA,
p = 0.055), with mice harboring the transplanted B6J donor
microbiota exhibiting marginally greater values compared to
129J-colonized mice (Figure 7D; Tukey’s honestly significant
difference, p = 0.075).
16S rRNA sequencing of fecal samples obtained from gnoto-
biotic mice belonging to the different treatment groups revealed
bacterial OTUs whose relative abundances correlated with the
measured mouse phenotypes. Using indicator species values,
MPA identified 119 97%ID OTUs that either differed significantly
in their relative abundances or frequencies among the colonized
gnotobiotic mice; 45 of these OTUs were previously identified as
being associated with at least one of the conventionally raised
mouse groups using phi-coefficients (Table S9). Of these, 31
(68.9%) were significantly associated with at least one of the
conventionally raised strains and a corresponding gnotobiotictabolism 22, 516–530, September 1, 2015 ª2015 Elsevier Inc. 525
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Figure 7. Gnotobiotic Mouse Experiments Identify Microbiota-
Transmissible Phenotypes in HFD-Fed Recipients
(A) Weight gain of germ-free (GF) C57Bl/6 mice (n = 5) and GF mice colonized
with fecal microbiota from B6J, 129J, and 129T (n = 9–10) mice fed a HFD
(repeated-measures two-way ANOVA [time and donor strain], with Tukey’s
post hoc tests).
(B) Random-fed blood glucose of mice from (A), after 6 weeks on HFD (one-
way ANOVA with Tukey’s post hoc test).
(C) AUC values calculated from data obtained during an oral glucose tolerance
tests at 8 weeks postcolonization. One exceptionally high outlier value was
removed from the mice colonized with the B6J microbiota prior to analysis.
(D) Liver weights for mice described in (A) after 8 weeks of HFD feeding (one-
way ANOVA with Tukey’s post hoc test) *p < 0.05, **p < 0.01, ***p < 0.0001. All
values presented as mean ± SEM.transplant recipient group. Twenty-five of the 119 OTUs were
previously identified as having correlations (before p value
corrections) with measured phenotypes in 129J or 129T mice
consuming HFD; however, the only OTU that was correlated in
the same direction with the same phenotype was OTU 227665
(Clostridium), which was consistently, negatively correlated
with body weight (Table S6C). Another OTU assigned to the
genus Clostridium (OTU 261590) was positively correlated
with liver weight in conventionally raised 129 mice and with
body weight across all three groups of gnotobiotic transplant
recipients.
Interestingly, four Bacteroidetes OTUs were significantly
negatively correlated with the oral glucose tolerance across all
three groups of recipient gnotobiotic animals. In fact, these
OTUs were undetectable in129T-colonized mice and present in
members of the other two treatment groups. Conversely, the
129T-associated OTU 261022 (Anaerotruncus colihominis) was
positively correlated with the AUC and was detected in all the
129T-colonized mice, but not the two other groups of recipients.
Together, these data show that colonizing germ-free C57Bl/6
mice, which are prone to obesity and metabolic syndrome, with
the microbiota from obesity-resistant 129Jmice partially amelio-
rates specific metabolic consequences of obesity, whereas526 Cell Metabolism 22, 516–530, September 1, 2015 ª2015 Elsevietransferring the microbiota from 129T mice, which are prone to
obesity but not metabolic syndrome, has less effect. In other
words, reshaping the gutmicrobiota can prevent certain features
of metabolic syndrome, and the resulting configuration of themi-
crobiota determines which phenotypes are altered and to what
extent.
DISCUSSION
Obesity, T2D, and metabolic syndrome are major health prob-
lems worldwide that pose financial and physical burdens to
both affected individuals and society as a whole. Thus, under-
standing the causes of these disorders and developing new ap-
proaches to prevention and treatment is a high priority. This is
made difficult, however, by the complex genetic and environ-
mental drives of these diseases, including factors such as host
genetics, diet, and the recently identified role of the gut micro-
biota. In the present study, we have explored the complex
interaction between these factors and different components of
metabolic syndrome using three inbred strains of mice from
two different vendors and three environmentally normalized lines
derived by inbreeding these strains in the same environment.
Our results demonstrate the strong and complex interrelation-
ships between host genetics, environment, gut microbiota, and
diet. They also demonstrate how exposure to a common envi-
ronment can remodel the gut microbiota and change the associ-
ated metabolic phenotypes in some strains of mice, while others
maintain their phenotypes despite the changing gut microbiota,
indicating a dominant genetic influence.
As previously observed (Almind and Kahn, 2004), C57Bl/6J
(B6J) mice on HFD exhibit robust weight gain and characteristics
of metabolic syndrome including insulin resistance, hyperglyce-
mia, and fatty liver, whereas 129S1/SvImJ (129J) mice, also
originating from the Jackson Laboratories, are resistant to
HFD-induced weight gain and insulin resistance. On the other
hand, a closely related 129 substrain of mice from Taconic
Farms, the 129S6/SvEvTac strain (129T), when challenged with
HFD becomes as heavy as the B6J mice and develops hepato-
megaly, but retains relatively good insulin sensitivity and glucose
tolerance, resulting in a ‘‘healthier’’ obese phenotype compared
to B6J mice.
To control for the differences in microbiota and other environ-
mental factors that are present at the different commercial facil-
ities (Harley et al., 2013), we inbred these three original strains in
our mouse facility for at least three generations. Comparison of
these environmentally normalized strains to their vendor-bred
counterparts disclosed that regardless of site of breeding and
housing, B6J mice were prone to obesity and metabolic syn-
drome, while 129J mice were resistant. 129T mice, on the other
hand, were prone to obesity and hepatosteatosis when vendor-
bred, but became resistant to these metabolic phenotypes after
three generations of breeding in a new environment. Transfer of
gut microbiota from the three vendor-born strains into germ-free
C57Bl/6 mice revealed no significant differences in weight gain
between the three recipient groups, but did demonstrate a signif-
icant microbiota-transmissible impact on glucose homeostasis,
with 129J donor microbiota conferring the most glucose tolerant
phenotype and the B6J donor microbiota producing the highest
fasting glucose levels.r Inc.
16S rRNA-based analysis of the fecal microbiota of the
vendor-bred strains revealed large differences between the
three strains, with 129T mice being the most distinct. As ex-
pected, all gut bacterial communities became more similar after
breeding in the common mouse facility; however, each line re-
tained a unique pattern resulting in distinct microbiota-host
phenotype correlations. The major differences in gut microbiota
of mice obtained from different commercial vendors, between
commercial and institutional animal facilities, and different time
points after some environmental change, even when using the
same diet, points out the need to control these variables as
much as possible within any experimental study.
Some of the correlations between phenotypes and bacterial
OTU representation that we identified in HFD-fed mice have
analogs in human metabolism. For example, the relative abun-
dance of Roseburia intestinalis, a butyrate producer, was corre-
lated with phenotypes in mice representing all three genetic
backgrounds fed HFD, including negative correlations with sub-
cutaneous adiposity, body weight, liver weight, serum insulin,
FGF21 levels, and inflammation markers. In humans, members
of the genus Roseburia have been reported to be negatively
correlated with plasma glucose (Larsen et al., 2010) and are
less abundant in the microbiota of individuals with T2D (Qin
et al., 2012). The abundance of Roseburia has been shown to in-
crease in the feces of individuals with metabolic syndrome who
receive fecal transplants from lean metabolically healthy donors,
and this has been associated with improved peripheral insulin
sensitivity (Vrieze et al., 2012). Butyrate produced by Roseburia
can serve as an important carbon source for colonic epithelial
cells and enhance mitochondrial function in peripheral tissues,
but the exact mechanisms underlying the positive metabolic
effects are not clear (Hartstra et al., 2015).
Other members of the Firmicutes also correlated with pheno-
types. For example, in HFD-fed B6J and B6J/Jos mice, which
develop the most severe manifestations of metabolic syndrome,
L. reuteri is strongly positively correlated with serum insulin
levels, as well as FGF21 levels. Similar correlations are observed
in the 129T-129T/Jos pair, which develops a mild form of meta-
bolic syndrome onHFD, but not in 129J-129J/Jos pair, which are
lean and insulin-sensitive on all diets. In humans, L. reuteri has
been observed to be more abundant in obese individuals than
in lean individuals (Million et al., 2012). The strong positive corre-
lation between the relative abundance of Lactobacillus gasseri
across all strains and diets is also of note, since Lactobacillus
species have also been shown to be correlated with glucose
levels in humans (Larsen et al., 2010), and L. gasseri was identi-
fied as the most discriminant taxon in the fecal microbiota of
normal glucose tolerant compared to type 2 diabetic women
(Karlsson et al., 2013). Moreover, Mucispirillum schaedleri, a
component of the Altered Schaedler’s flora, initially used to colo-
nize animals stocking the Taconic barrier rooms, is significantly
associated with 129T, but not 129T/Jos, mice and positively
correlated with body weight gain in the 129T mice.
Although 129T and 129T/Jos mice have less adipose inflam-
mation than B6J mice, even at similar body weights, in the 129T
genetic background, markers of adipose inflammation also best
correlate with two OTUs assigned to the genus Lactobacillus
(OTU 292302 [L. murinus] and OTU 422931). In B6J mice, we
find markers of adipose inflammation to correlate with levelsCell Meof Akkermansia muciniphila However, this association of Akker-
mansia with adipose tissue inflammation is restricted to B6J
and is not observed in B6J/Jos mice (Figures S5E and S5F),
indicating that other cosegregating microbes may be contrib-
uting to this correlation. This is further suggested by previous
findings that administration of Akkermansia muciniphila can
have beneficial metabolic effects on body weight, adipose
tissue inflammation, and glucose tolerance (Everard et al.,
2013), with similar associations in humans (Tilg and Moschen,
2014). Therefore the correlation between this microbe and the
immunological phenotypes may be part of changes in larger
microbial communities that either directly or via effects on
metabolism or the immune system modulate host physiology.
In line with previous studies (Harley et al., 2013), we could not
detect any significant correlations between any of metabolic
phenotypes and members of the segmented filamentous
bacteria (SFB), which are known modulators of IL-17 secretion
(Ivanov et al., 2009).
In summary, obesity, T2D, and metabolic syndrome are the
results of complex interactions between genetic and environ-
mental factors, including the gut microbial community. As a
result, when genetically identical mice are raised in different en-
vironments and challenged with HFD, there may be major differ-
ences in the composition of the gut microbiota that can impact
on the development of obesity, hepatosteatosis, insulin resis-
tance, and other components of metabolic syndrome. Indeed,
in some genetic backgrounds (such as 129S6/SvEvTac), envi-
ronmental reshaping of the microbiota can significantly amelio-
rate development of features of the metabolic syndrome,
whereas in other backgrounds (such as C57Bl/6J), strong ge-
netic influences may be dominant. These interactions between
diet, genetics, and the microbiota present a great challenge in
any analysis of both preclinical models and human disease.
Transplanting microbiota from donors with distinct phenotypes
and microbial communities into mice representing different
genetic backgrounds can be used to help establish a causal
relationship between microbes and host biology, and also iden-
tify interactions between host genetic background and the
microbiota. Developing strategies to manipulate the microbiota
that drive specific components of the metabolic syndrome,
especially those components that interact with a permissive
host genetic background, may open the door to new strategies
for effective and more durable ways of treating disease and ulti-
mately preventing it.
EXPERIMENTAL PROCEDURES
Additional details of all methods are provided in Supplemental Experimental
Procedures.
Animals and Diets
Animal care and study protocols were approved by the Animal Care Commit-
tees of the Joslin Diabetes Center and Washington University, and were in
accordance with the National Institutes of Health guidelines. All mice were
housed in the Joslin Diabetes Center mouse facility on a 12 hr light/dark cycle
in a 22C temperature-controlled room. C57BL/6J and 129S1/SvImJ animals
were purchased from Jackson Laboratories (Bar Harbor, ME) at 3 weeks of
age, and 129S6/SvEvTacmice were purchased from Taconic Farms (German-
town, NY), also at 3 weeks of age. Each of the three lines was inbred at the Jo-
slin Diabetes Center for three to six generations. Animals were maintained on
NIH-31M diet (Taconic, composed of 14% calories from fat, 24% from protein,tabolism 22, 516–530, September 1, 2015 ª2015 Elsevier Inc. 527
and 62% from carbohydrates) or a HFD (Research Diets D12492, composed of
60% calories from fat, 20% calories from protein, and 20% calories from
carbohydrates).
Inbred colonies from 129Jax and 129Tacmice were established in the Joslin
animal facility for three consecutive generations. At the fourth generation,
feces were sampled from 3-week-old animals (B6 Jax/Jos, 129Tac/Jos, and
129 Jax/Jos) as well as from aged-matched vendor-born animals immediately
upon delivery at the Joslin vivarium (B6Jax, 129Jax, and 129 Jos). Following
initial sampling, mice from each colony were given either CD or HFD. Feces
were collected for DNA extraction after 1, 8, and 22 weeks to assess short-
term, medium-term, and long-term effects of diet and environmental exposure
on microbiota composition. Great care was taken to perform physiological
tests and collect samples at uniform time, since regulation of host metabolism
and gut microbiota composition have been shown to have diurnal fluctuations
(Thaiss et al., 2014; Zarrinpar et al., 2014).
Gnotobiotic Transfer Experiments
Germ-free (GF) male C57BL/6J mice were obtained from the Center for Meta-
genomics gnotobiotic core facility at Brigham and Women’s Hospital. Four
groups of 5-week-old GFmice were fed HFD (60% calories from fat; Research
Diet) for 1 week. Subsequently mice were divided into three groups and
colonized with cecal microbiota collected from age-matched donors, or
maintained as germ-free control. Donor microbiota were prepared from
conventionally raised B6J, 129J, and 129Tmice purchased from Jackson Lab-
oratories or Taconic Farms at the date of transfer. Ceca from donor conven-
tional mice were removed and transferred into a Coy anaerobic chamber,
where they were placed in sterile prereduced PBS supplemented with
40 mM cysteine and manually homogenized with a sterile Dounce homogeniz-
er to create a suspension. Materials were sealed in the hood and transferred to
gnotobiotic isolators to colonize gnotobiotic recipients by oral-gastric gavage
with 200 ml of the materials. An additional 200 uL of material was spread over
the fur and anus of mice. Mice were maintained in plastic flexible film gnotobi-
otic isolators (five mice per cage) on a strict 12 hr light cycle (lights on at 6 a.m.)
and fed HFD for 8 weeks after colonization.
Microbiota Analysis
Multiplex sequencing of bacterial V4-16S rRNA amplicons was performed
using an Illumina MiSeq instrument and DNA primer sets and protocols
described elsewhere (Bokulich et al., 2013) with an average of 19,740 ± 254
reads (mean ± SEM) per sample from the conventionally raised animals (Table
S1A). Reads were binned into operational taxonomic units sharing 97%
nucleotide sequence identity (97%ID OTUs, or OTUs for short) and given a
taxonomic assignment. The software package QIIME v.1.50-dev was used
to pick 97% ID OTUs, filter, and rarefy the sequence data. A phylogenetic
tree of the OTUs was constructed. Sequences were aligned with PyNast;
sequences that could not be aligned were discarded (Caporaso et al., 2010).
Taxonomy was assigned to each OTU using the RDP v. 2.4 classifier method
(Wang et al., 2007).
To investigate the fecal microbiota of the colonized gnotobiotic recipient an-
imals, we performed multiplex sequencing of bacterial V4-16S rRNA ampli-
cons as described above, with an average of 71,030 ± 4,137 reads (mean ±
SEM) per sample (Table S1B). The data were rarefied to 30,000 reads per sam-
ple prior to analysis. To identify OTUs that differed in their relative abundances
or frequencies in the colonized gnotobiotic mice, we performed MPA as
above, but used species indicator values instead of phi-coefficients. OTUs
that occurred in at least 20% of the mice in a treatment group and had a
mean relative abundance of at least 0.1% in a treatment group were included
in the analysis. p values were FDR corrected. We also calculated Spearman’s
rank correlations between the relative abundances of OTUs and the pheno-
types measured in the gnotobiotic transplant recipients. These correlations
were calculated across all treatment groups, and OTUs with a mean relative
abundance of at least 0.01% across all samples were included in the analysis.
p values were FDR corrected.
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